Ovarian Cancer Trial, Not Yet Recruiting NCT06558019 Sponsor: Lei Li Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Not Yet Recruiting

NCT06558019
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women aged 18 years or older
  • People who have been diagnosed through laboratory testing with stage I to stage IV epithelial ovarian cancer (a specific type of ovarian cancer)
  • People whose physical functioning is rated at a certain level based on a standard medical scale, meaning they are able to carry out at least some daily activities (confirm with trial site)
  • People whose doctors expect them to live for more than 6 months
  • People who enroll within 8 weeks of receiving their diagnosis
  • People who are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a type of ovarian tumour that is not classified as epithelial (a different category of ovarian tumour)
  • People who have had another cancer diagnosis within the past 5 years
  • People who have already received systemic treatment (such as chemotherapy or other body-wide treatments) for ovarian cancer
  • People who are currently pregnant
  • People who have previously had both ovaries surgically removed

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lei Li, M.D., Peking Union Medical College Hospital

Phone: 86-139-1198-8831

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Lei Li
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

progression-free survival; overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov